Peripheral vascular disease is strongly associated to cardiovascular events and a negative impact on health status and quality of life. However, researchers are yet to determine the benefit of early intervention in patients presenting intermittent claudication, and whether it improves quality of life. At present, there is little information in this regard (CLEVER trial), and...
INDUSTRY SPONSORED ACTIVITIES Just like every year, the unconditional support of the industry to SOLACI Congress is a fundamental aspect to guarantee the academic excellence and quality of our scientific content. This is why we are inviting you to find out more about the important activities we will be carrying out at SOLACI-SOCIME 2022. Register...
There is a consistent number of patients presenting high risk of bleeding. In this context, receiving dual antiplatelet therapy (DAPT) for 12 months would not be advisable. Even though the European and American guidelines recommend 1 to 6 months for chronic and acute syndromes in this group, these are often complex PCI cases, which makes...
The 44th issue of SOLACI Regional Sessions to be held in Paraguay is open for registration. The event will take place at the convention center of Galería de Asunción, Paraguay, and will be featuring an attractive scientific proposal with the current most controversial topics in interventional cardiology. With our Regional Sessions, SOLACI continues to integrate...
Takotsubo Syndrome (STT) is characterized by acute cardiac failure which can be reversed in many occasions, but is associated with morbidity and mortality at short and long term. It is most frequent among women, especially after menopause. However, gender differences have not been looked into when analyzing the evolution of this cardiomyopathy. This was an...
The most outstanding professionals in the world in the specialty attend the SOLACI Congresses. Discover the international guests who will share their knowledge at SOLACI-SOCIME 2022 and register today with 15% off before July 13. Register Now with 15% off
The proportion of patients treated with coronary angioplasty who are at a high risk for bleeding is increasing. In this population, extended dual antithrombotic therapy increases the risk of bleeding. The 1-year randomized Onyx one study has demonstrated the non-inferiority of zotarolimus-eluting stents (ZES) vs. biolimus-coated polymer-free stent BioFreedom (DCS). Patients received dual-antiplatelet therapy (DAPT)...
You can now take part in one of the most relevant events of the year in interventional cardiology with amazing discounts! Sign up and make part of an International Congress where you will be able to enjoy: Challenging live cases Prestigious international guests Joint sessions with the world’s most relevant scientific societies in the field...
August is the month in which we meet again to continue developing interventional cardiology on the continent. Discover all the attractions of an unmissable event: Register Now First International Faculties Confirmed Meet some of the renowned specialists who will be part of the event. Call For Science: Send Your Work Submit your work now and...
PCI success rate in chronic total occlusion (CTO), according to some registries, is below 80%. These failed revascularization procedures might lead to quality-of-life deterioration and shorter survival. This concern has driven the development of new techniques and technologies in an attempt to increase PCI success. Today, approximately 20% of CTOs are treated with a second...